Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis

被引:9
|
作者
Thayakaran, R. [1 ]
Perrins, M. [1 ]
Gokhale, K. M. [1 ]
Kumaran, S. [1 ]
Narendran, P. [2 ,3 ]
Price, M. J. [1 ,6 ,7 ]
Nirantharakumar, K. [1 ,2 ,4 ,5 ]
Toulis, K. A. [1 ]
机构
[1] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Dept Diabet, Birmingham, W Midlands, England
[3] Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[4] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England
[5] Hlth Data Res UK Midlands, Birmingham, W Midlands, England
[6] Univ Hosp Birmingham NHS Fdn Trust, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England
[7] Univ Birmingham, Birmingham, W Midlands, England
关键词
ALL-CAUSE MORTALITY; MELLITUS; METAANALYSIS; COMPLICATIONS; DEPRIVATION; MECHANISMS; GLUCOSE; COHORT;
D O I
10.1111/dme.13945
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess whether glycaemic control is associated with a lifelong increased risk of fracture in people with newly diagnosed Type 1 diabetes. Methods People with newly diagnosed Type 1 diabetes between 1 January 1995 and 10 May 2016 were identified in The Health Improvement Network database. Longitudinal HbA(1c) measurements from diagnosis to fracture or study end or loss to follow-up were collected. A Cox proportional hazards model with HbA(1c) included as a time-dependent variable was fitted to these data. Results Some 5368 people with newly diagnosed Type 1 diabetes were included. The estimated adjusted hazard ratio (aHR) for HbA(1c) was statistically significant [aHR 1.007; 95% confidence interval (CI) 1.002-1.011 (mmol/mol) and aHR 1.07; 95% CI 1.03-1.12 (%)]. An incremental higher risk of fracture was observed with increasing levels of HbA(1c). Conclusions In people with newly diagnosed Type 1 diabetes, higher HbA(1c) is associated with an increased risk for fractures.
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 50 条
  • [1] Socioeconomic inequalities in glycaemic control in people with newly diagnosed type 1 and type 2 diabetes
    Jacobs, E.
    Strassburger, K.
    Icks, A.
    Kuss, O.
    Burkhart, V.
    Szendroedi, J.
    Muessig, K.
    Rathmann, W.
    Roden, M.
    [J]. DIABETOLOGIA, 2018, 61 : S420 - S420
  • [2] The impact of sedentary time and breaks in sedentary time on glycaemic control in people with Type 2 diabetes
    Paing, A. C.
    McMillan, K. A.
    Kirk, A.
    Collier, A.
    Hewitt, A.
    Chastin, S. F. M.
    [J]. DIABETIC MEDICINE, 2018, 35 : 83 - 83
  • [3] Interventions in people newly diagnosed with type 1 diabetes mellitus
    Claire Greenhill
    [J]. Nature Reviews Endocrinology, 2023, 19 : 252 - 252
  • [4] Interventions in people newly diagnosed with type 1 diabetes mellitus
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (05) : 252 - 252
  • [5] The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data
    Hellgren, Margareta
    Svensson, Ann-Marie
    Franzen, Stefan
    Ericsson, Asa
    Gudbjornsdottir, Soffia
    Ekstrom, Nils
    Bertilsson, Rebecka
    Valentine, William
    Malkin, Samuel
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1604 - 1613
  • [6] Glycaemic control and antibody status among Waikato, New Zealand patients with newly diagnosed Type 1 diabetes
    Hickey, Doron
    Joshy, Grace
    Dunn, Peter
    Simmons, David
    Lawrenson, Ross
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2007, 120 (1262) : 53 - 60
  • [7] Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
    R. N. Guzder
    W. Gatling
    M. A. Mullee
    C. D. Byrne
    [J]. Diabetologia, 2006, 49 : 49 - 55
  • [8] Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
    Guzder, RN
    Gatling, W
    Mullee, MA
    Byrne, CD
    [J]. DIABETOLOGIA, 2006, 49 (01) : 49 - 55
  • [9] Is glycaemic control associated with dietary patterns independent of weight change in people newly diagnosed with type 2 diabetes? Prospective analysis of the Early-ACTivity-In-Diabetes trial
    James Garbutt
    C. England
    A. G. Jones
    R. C. Andrews
    R. Salway
    L. Johnson
    [J]. BMC Medicine, 20
  • [10] Is glycaemic control associated with dietary patterns independent of weight change in people newly diagnosed with type 2 diabetes? Prospective analysis of the Early-ACTivity-In-Diabetes trial
    Garbutt, James
    England, C.
    Jones, A. G.
    Andrews, R. C.
    Salway, R.
    Johnson, L.
    [J]. BMC MEDICINE, 2022, 20 (01)